These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7906451)

  • 1. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
    Rossen K; Hou-Jensen K; Werdelin O
    Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
    Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
    Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.
    Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
    Br J Dermatol; 1997 Jan; 136(1):30-4. PubMed ID: 9039291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
    Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
    APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basal cell carcinoma overlying a dermatofibroma].
    Córdoba S; Hernández A; Romero A; Arias D; Castaño E; García-Donoso C; Borbujo JM
    Actas Dermosifiliogr; 2005 Nov; 96(9):612-5. PubMed ID: 16476308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
    Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
    J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal basaloid proliferation in cutaneous myxomas.
    Mehregan DR; Thomas L; Thomas JE
    J Cutan Pathol; 2003 Sep; 30(8):499-503. PubMed ID: 12950501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
    Han KH; Huh CH; Cho KH
    Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
    Goette DK; Helwig EB
    Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
    Lindboe CF; Løvdal L
    Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME; Smith K; Corbett D; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
    Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
    J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma overlying a dermatofibroma: a revisited controversy.
    Rosmaninho A; Farrajota P; Peixoto C; Amorim I; Selores M
    Eur J Dermatol; 2011; 21(1):137-8. PubMed ID: 21233074
    [No Abstract]   [Full Text] [Related]  

  • 14. Follicular basal cell hyperplasia overlying dermatofibroma.
    Cheng L; Amini SB; Tarif Zaim M
    Am J Surg Pathol; 1997 Jun; 21(6):711-8. PubMed ID: 9199650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibroma: upregulation of syndecan-1 expression in mesenchymal tissue.
    Sellheyer K; Smoller BR
    Am J Dermatopathol; 2003 Oct; 25(5):392-8. PubMed ID: 14501288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The man behind the eponym: Hans Biberstein and follicular hyperplasia overlying dermatofibroma.
    Hamel J; Burgdorf WH; Bräuninger W
    Am J Dermatopathol; 2009 Oct; 31(7):710-4. PubMed ID: 19633531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistologic study of cellular populations of histiocytofibromas ("dermatofibromas").
    Kanitakis J; Schmitt D; Thivolet J
    J Cutan Pathol; 1984 Apr; 11(2):88-94. PubMed ID: 6330187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary sclerotic fibroma of the skin: a sclerotic dermatofibroma?
    Pujol RM; de Castro F; Schroeter AL; Su WP
    Am J Dermatopathol; 1996 Dec; 18(6):620-4. PubMed ID: 8989937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lichenoid, erosive and ulcerated dermatofibromas. Three additional clinico-pathologic variants.
    Sánchez Yus E; Soria L; de Eusebio E; Requena L
    J Cutan Pathol; 2000 Mar; 27(3):112-7. PubMed ID: 10728811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sebaceous hyperplasia overlying a dermatofibroma.
    Davis TT; Calilao G; Fretzin D
    Am J Dermatopathol; 2006 Apr; 28(2):155-7. PubMed ID: 16625080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.